Clinical Trial Update: Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition. [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing test product Ertugliflozin/Metformin 7.5 mg/1000 mg film-coated tablets to Segluromet 7.5 mg/1000 mg film-coated tablets …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ertugliflozin/metformin 7.5 mg/1000 mg film-coated tablets (test product) (ertugliflozin/metformin)
• Segluromet 7.5 mg/1000 mg Film Coated Tablets (ertugliflozin/metformin)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED